Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Hippocampal mitochondrial dysfunction and psychiatric-relevant behavioral deficits in spinocerebellar ataxia 1 mouse model

F. Tichanek, M. Salomova, J. Jedlicka, J. Kuncova, P. Pitule, T. Macanova, Z. Petrankova, Z. Tuma, J. Cendelin,

. 2020 ; 10 (1) : 5418. [pub] 20200325

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028361

Spinocerebellar ataxia 1 (SCA1) is a devastating neurodegenerative disease associated with cerebellar degeneration and motor deficits. However, many patients also exhibit neuropsychiatric impairments such as depression and apathy; nevertheless, the existence of a causal link between the psychiatric symptoms and SCA1 neuropathology remains controversial. This study aimed to explore behavioral deficits in a knock-in mouse SCA1 (SCA1154Q/2Q) model and to identify the underlying neuropathology. We found that the SCA1 mice exhibit previously undescribed behavioral impairments such as increased anxiety- and depressive-like behavior and reduced prepulse inhibition and cognitive flexibility. Surprisingly, non-motor deficits characterize the early SCA1 stage in mice better than does ataxia. Moreover, the SCA1 mice exhibit significant hippocampal atrophy with decreased plasticity-related markers and markedly impaired neurogenesis. Interestingly, the hippocampal atrophy commences earlier than the cerebellar degeneration and directly reflects the individual severity of some of the behavioral deficits. Finally, mitochondrial respirometry suggests profound mitochondrial dysfunction in the hippocampus, but not in the cerebellum of the young SCA1 mice. These findings imply the essential role of hippocampal impairments, associated with profound mitochondrial dysfunction, in SCA1 behavioral deficits. Moreover, they underline the view of SCA1 as a complex neurodegenerative disease and suggest new avenues in the search for novel SCA1 therapies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028361
003      
CZ-PrNML
005      
20250819110841.0
007      
ta
008      
210105s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-020-62308-0 $2 doi
035    __
$a (PubMed)32214165
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Tichánek, Filip $u Department of Pathological Physiology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia. f.tichanek@gmail.com. Laboratory of Neurodegenerative Disorders, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia. f.tichanek@gmail.com. $7 xx0334827
245    10
$a Hippocampal mitochondrial dysfunction and psychiatric-relevant behavioral deficits in spinocerebellar ataxia 1 mouse model / $c F. Tichanek, M. Salomova, J. Jedlicka, J. Kuncova, P. Pitule, T. Macanova, Z. Petrankova, Z. Tuma, J. Cendelin,
520    9_
$a Spinocerebellar ataxia 1 (SCA1) is a devastating neurodegenerative disease associated with cerebellar degeneration and motor deficits. However, many patients also exhibit neuropsychiatric impairments such as depression and apathy; nevertheless, the existence of a causal link between the psychiatric symptoms and SCA1 neuropathology remains controversial. This study aimed to explore behavioral deficits in a knock-in mouse SCA1 (SCA1154Q/2Q) model and to identify the underlying neuropathology. We found that the SCA1 mice exhibit previously undescribed behavioral impairments such as increased anxiety- and depressive-like behavior and reduced prepulse inhibition and cognitive flexibility. Surprisingly, non-motor deficits characterize the early SCA1 stage in mice better than does ataxia. Moreover, the SCA1 mice exhibit significant hippocampal atrophy with decreased plasticity-related markers and markedly impaired neurogenesis. Interestingly, the hippocampal atrophy commences earlier than the cerebellar degeneration and directly reflects the individual severity of some of the behavioral deficits. Finally, mitochondrial respirometry suggests profound mitochondrial dysfunction in the hippocampus, but not in the cerebellum of the young SCA1 mice. These findings imply the essential role of hippocampal impairments, associated with profound mitochondrial dysfunction, in SCA1 behavioral deficits. Moreover, they underline the view of SCA1 as a complex neurodegenerative disease and suggest new avenues in the search for novel SCA1 therapies.
650    _2
$a zvířata $7 D000818
650    _2
$a atrofie $x metabolismus $x patologie $7 D001284
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a mozeček $x metabolismus $x patologie $7 D002531
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a hipokampus $x metabolismus $x patologie $7 D006624
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a duševní poruchy $x metabolismus $x patologie $7 D001523
650    _2
$a myši $7 D051379
650    _2
$a mitochondrie $x metabolismus $x patologie $7 D008928
650    _2
$a spinocerebelární ataxie $x metabolismus $x patologie $7 D020754
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Salomova, Martina $u Department of Pathological Physiology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia. Laboratory of Neurodegenerative Disorders, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
700    1_
$a Jedlicka, Jan $u Department of Physiology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia. Mitochondrial Laboratory, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
700    1_
$a Kuncova, Jitka $u Department of Physiology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia. Mitochondrial Laboratory, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
700    1_
$a Pitule, Pavel $u Laboratory of Tumor Biology, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
700    1_
$a Macanova, Tereza $u Department of Biology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
700    1_
$a Petrankova, Zuzana $u Department of Pathological Physiology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
700    1_
$a Tuma, Zdenek $u Laboratory of Proteomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
700    1_
$a Cendelin, Jan $u Department of Pathological Physiology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia. Laboratory of Neurodegenerative Disorders, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 10, č. 1 (2020), s. 5418
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32214165 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20250819110823 $b ABA008
999    __
$a ok $b bmc $g 1608696 $s 1119541
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c 1 $d 5418 $e 20200325 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace